TrialRheumatology (Oxford, England)2010
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study.
Dimitrios Daoussis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
144 papers cite itlatest 60 shown
this paperpooled ittrialcites it